Sanofi adds diabetes to collaborative effort at UCSF

Sanofi ($SNY) is broadening its research ties with the University of California in San Francisco, which has been steadily growing its collaborative work with the biopharma industry under Chancellor Susan Desmond-Hellmann. In the new $3.1 million pact, Sanofi researchers will work with investigators on new treatments for diabetes. Scientists are already joining forces with Sanofi on brain trauma and oncology. Release